The search for a reliable marker to predict pregnancy success is not yet identified. This study aims to evaluate paraoxonase activities (PON1) in follicular fluid (FF) and their correlation with oocyte yield, fertilization, and clinical pregnancy (CP). Methods: The study included 99 women aged 22-37 years old who were undergoing IVF/ICSI, were divided into fertile, which represents the control group consisting of 25 participants, and the infertile group, which was subdivided into 21 patients with PCOS, 26 patients with a low level of AMH, as well as 27 patients with unknown cause of infertility. The FF Basal PON1, salt stimulated PON1, and arylesterase activities were measured using the spectrophotometry method. Results: The PON1 basal activity of the PCOS group was higher (P<0.05) when compared with the control and UI groups. The PON1 arylesterase activity of the PCOS group was higher (P<0.05) when compared with control, UI, and low AMH groups. Each group showed a difference (P<0.05)in the pregnancy success in PCOS, low AMH, and UI groups but not in the control group. Conclusion: An increase in FF antioxidants seems to be a negative fertilization indicator, which may represent an adverse ovarian condition that triggered anti-oxidant behavior.
, 290 patients were examined for sexually transmitted diseases in three venereal disease clinics in Khartoum Province. Clinical and laboratory findings showed that nongonococcal urethritis was the commonest STD in men (35.1 lo), with gonorrhoea the second commonest (25.9%). Most of the patients with STDs were aged between 20 and 39 years. Of the infected men, 49.3070 had acquired their infections from prostitutes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.